BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23791336)

  • 1. Immunosuppression for membranous nephropathy.
    Cirillo M
    Lancet; 2013 Jun; 381(9884):2161. PubMed ID: 23791336
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression for membranous nephropathy.
    Hofstra J; Wetzels J
    Lancet; 2013 Jun; 381(9884):2162. PubMed ID: 23791340
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression for membranous nephropathy.
    Chen Z; Du X
    Lancet; 2013 Jun; 381(9884):2162-3. PubMed ID: 23791339
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression for membranous nephropathy.
    Gödel M; Huber TB
    Lancet; 2013 Jun; 381(9884):2161. PubMed ID: 23791337
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression for membranous nephropathy.
    Dhaun N; Kluth DC
    Lancet; 2013 Jun; 381(9884):2161-2. PubMed ID: 23791338
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Prednisolone plus chlorambucil preserved renal function in membranous nephropathy.
    Remuzzi G; Ruggenenti P
    Ann Intern Med; 2013 May; 158(10):JC9. PubMed ID: 23689788
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression for membranous nephropathy - Authors' reply.
    Mathieson PW
    Lancet; 2013 Jun; 381(9884):2163. PubMed ID: 23791342
    [No Abstract]   [Full Text] [Related]  

  • 8. Idiopathic membranous nephropathy: back to the future?
    Ruggenenti P; Remuzzi G
    Lancet; 2013 Mar; 381(9868):706-8. PubMed ID: 23312809
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
    Howman A; Chapman TL; Langdon MM; Ferguson C; Adu D; Feehally J; Gaskin GJ; Jayne DR; O'Donoghue D; Boulton-Jones M; Mathieson PW
    Lancet; 2013 Mar; 381(9868):744-51. PubMed ID: 23312808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A difficult trade off for adults with membranous nephropathy.
    BMJ; 2013 Jan; 346():f248. PubMed ID: 23325868
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression for membranous nephropathy.
    Lancet; 1988 Dec; 2(8624):1361-2. PubMed ID: 2904068
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined administration of low-dose prednisolone and cyclosporine in idiopathic membranous nephropathy: Tsukuba's regimen for IMN.
    Usui J; Hirayama K; Suzuki S; Koyama A; Yamagata K
    Clin Exp Nephrol; 2012 Aug; 16(4):654-5. PubMed ID: 22644092
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of membranous nephropathy.
    Ponticelli C; Passerini P
    Nephrol Dial Transplant; 2001; 16 Suppl 5():8-10. PubMed ID: 11509678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of membranous nephropathy with prednisolone and chlorambucil.
    Mavromatidis C; Spaia S; Christidou F; Vayonas G
    Lancet; 1989 May; 1(8645):1015. PubMed ID: 2565486
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporin A-induced remission of primary membranous glomerulonephritis in a child.
    Pape L; Mengel M; Offner G; Ehrich JH
    Nephrol Dial Transplant; 2004 Dec; 19(12):3207. PubMed ID: 15575018
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of idiopathic membranous nephropathy (IMN).
    Alexopoulos E; Papagianni A
    Ren Fail; 2000 Nov; 22(6):697-709. PubMed ID: 11104159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
    Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
    Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tonsillar Kaposi sarcoma in a patient with membranous glomerulonephritis on immunosuppressive therapy.
    Al-Brahim N; Zaki AH; El-Merhi K; Ahmad MS
    Ear Nose Throat J; 2013 Jul; 92(7):E1-4. PubMed ID: 23904308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
    Hebert LA; Rovin BH; Agarwal AK; Spetie DN
    Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.